Loading...
XLONINHC
Market cap10mUSD
Dec 24, Last price  
9.00GBP
1D
0.00%
1Q
20.00%
IPO
-92.47%
Name

Induction Healthcare Group PLC

Chart & Performance

D1W1MN
XLON:INHC chart
P/E
P/S
60.87
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
48.89%
Rev. gr., 5y
%
Revenues
14m
+5.93%
0148,0001,361,0007,231,00012,884,00013,648,000
Net income
-3m
L-81.26%
-2,707,000-3,527,000-7,614,000-8,432,000-17,383,000-3,257,000
CFO
-1m
L-61.29%
-2,163,000-3,346,000-4,011,999-2,061,000-2,808,000-1,087,000
Earnings
Jul 02, 2025

Profile

Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, Europe, the United States, and internationally. The company offers Induction Switch that allows healthcare professionals to bypass the hospital's switchboard, helping them locate extensions, return bleeps quickly or send instant, and role-based messages in a secure environment; Induction Zesty, a software-as-a-service platform, which allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical records, and provide data to their care teams remotely; and Induction Guidance, a platform to create, edit, and publish their own local guidance and policies. It also provides Induction Outpatient Parenteral Antimicrobial Therapy Management System, a cloud-based solution that allows the management of patients and monitoring of the OPAT patient journey; Induction Booking, an online booking platform for patients, hospital staffs, and care home staffs; Induction HealthStream, a data integration platform that reads and writes patient demographic, appointment, and clinical record data; and Induction Attend Anywhere, which offers video consultations to patients and service users to help hospitals, health systems, and other customers. The company was incorporated in 2019 and is based in London, the United Kingdom.
IPO date
May 22, 2019
Employees
77
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑03
Income
Revenues
13,648
5.93%
12,884
78.18%
7,231
431.30%
Cost of revenue
17,850
27,149
19,750
Unusual Expense (Income)
NOPBT
(4,202)
(14,265)
(12,519)
NOPBT Margin
Operating Taxes
(962)
(798)
(1,082)
Tax Rate
NOPAT
(3,240)
(13,467)
(11,437)
Net income
(3,257)
-81.26%
(17,383)
106.16%
(8,432)
10.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
7
2
23,810
BB yield
-0.05%
-0.01%
-71.29%
Debt
Debt current
57
72
72
Long-term debt
57
112
184
Deferred revenue
3,920
3,588
326
Other long-term liabilities
Net debt
(3,576)
(19,363)
(28,446)
Cash flow
Cash from operating activities
(1,087)
(2,808)
(2,061)
CAPEX
(329)
(827)
(3,346)
Cash from investing activities
421
(827)
(16,832)
Cash from financing activities
(63)
(70)
24,008
FCF
(4,373)
(14,326)
(11,666)
Balance
Cash
3,690
4,287
7,496
Long term investments
15,260
21,206
Excess cash
3,008
18,903
28,340
Stockholders' equity
(41,801)
(17,369)
598
Invested Capital
66,158
44,677
41,402
ROIC
ROCE
EV
Common stock shares outstanding
92,782
92,370
82,462
Price
0.16
-27.91%
0.22
-46.91%
0.41
-62.33%
Market cap
14,381
-27.59%
19,860
-40.53%
33,397
-21.75%
EV
10,805
497
4,951
EBITDA
(171)
(9,632)
(8,705)
EV/EBITDA
Interest
11
7
30
Interest/NOPBT